Product Information
LANSOPRAZOLE DR 30 MG ODT is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $2.1807 per EA under NDC 00093300993. Its NADAC has been published 410 times since Aug 22, 2018.
Strength
30 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093300993
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LANSOPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA208784On Market Since
3/8/2018
Pharmacological Classes
Price Statistics
The NADAC for LANSOPRAZOLE DR 30 MG ODT has been published 410 times since Aug 22, 2018, and over the history we have for it it has declined 80.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1807 per EA |
|---|---|
| All-time high | $11.2227 (Jun 12, 2019) |
| All-time low | $1.8384 (Apr 22, 2026) |
| 52-week high | $3.1027 |
| 52-week low | $1.8384 |
| Median price | $4.6410 |
| Average price | $5.4577 |
| Largest weekly change | +43.5% (Sep 22, 2021) |
| Weeks tracked | 410 |
| Tracking since | Aug 22, 2018 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LANSOPRAZOLE DR 30 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for LANSOPRAZOLE DR 30 MG ODT, manufactured by Teva Pharmaceuticals USA Inc., is $2.1807 per EA (NDC 00093300993), effective Jun 24, 2026.
How has the price of LANSOPRAZOLE DR 30 MG ODT changed over time?
Over the history we have for it, the NADAC for LANSOPRAZOLE DR 30 MG ODT has declined 80.1%. It has been tracked across 410 weekly CMS publications since Aug 22, 2018.
What are the highest and lowest recorded NADAC prices for LANSOPRAZOLE DR 30 MG ODT?
Since Aug 22, 2018, the NADAC for LANSOPRAZOLE DR 30 MG ODT has ranged from a low of $1.8384 (Apr 22, 2026) to a high of $11.2227 (Jun 12, 2019), with a median of $4.6410 per EA.
Are there cheaper alternatives to LANSOPRAZOLE DR 30 MG ODT?
Yes. 9 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LANSOPRAZOLE DR 30 MG CAPSULE, is $0.1067 per EA — about 95% below LANSOPRAZOLE DR 30 MG ODT.
Who manufactures LANSOPRAZOLE DR 30 MG ODT?
LANSOPRAZOLE DR 30 MG ODT (NDC 00093300993) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification